IFITM1 and Epstein-Barr virus infection: Our data revealed that IFITM1 had an adverse impact on EBV infection, which is not consistent with the conclusion in ref. 32 that IFITM1 facilitated EBV infection in B (BJAB) and endothelial (HMVEC-d) cells.